Ultrasound Features Using MUSA Terms and Definitions in Uterine Sarcoma and Leiomyoma

Ultrasound Obstet Gynecol.
May 10, 2024

A postmenopausal patient presenting with abnormal uterine bleeding and a new or growing mesenchymal mass with irregular tumor borders, moderate-to-abundant intralesional vascularity, cystic areas and an absence of calcifications on ultrasonography is at a higher risk of having a uterine sarcoma. Interobserver agreement for most MUSA terms and definitions is moderate.

Read More

Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis

Clin J Am Soc Nephrol.
May 09, 2024

Kidney outcome in patients with biopsied IgA vasculitis nephritis treated with immunosuppression was determined by clinical risk factors and endocapillary hypercellularity (E1) and fibrous crescents, which are features that are not part of the International Study of Diseases of Children classification.

Read More

Metastasis Of Skin Squamous Cell Carcinoma In Kidney Transplant Recipients

Int J Dermatol
May 08, 2024

Both groups, KTRs and ICs, exhibited similar primary tumor grades and metastasis evolution, but KTRs had a higher prevalence of lymphovascular invasion. Metastasis of cSCC was more common in males with low skin phototype, in KTRs, particularly on the head and neck. The study suggests a possible link between lymphovascular invasion and metastasis development in KTRs.

Read More

Telehealth Privacy and Security Tips

Skyscape
May 17, 2024

Buzz, a HIPAA-complaint platform enables providers to conduct secure video conferences or calls with patients quickly, easily & seamlessly.

Read More

Pharmacological Treatments in Heart Failure With Mildly Reduced and Preserved Ejection Fraction

J Am Coll Cardiol HF
May 08, 2024

In patients with HF and LVEF more than 40%, the quadruple combination of ARNI, BB, MRA, and SGLT2i provides the largest reduction in the risk of CV death and HHF; driven by the robust effect of the triple combination of ARNI, MRA, and SGLT2i. The benefit was more pronounced in HFmrEF patients.

Read More

Probable Non-Ventilator-Associated Hospital-Acquired Pneumonia

Crit Care Nurse
May 07, 2024

Consistent oral care, early and frequent physical activity, and measures aimed to reduce aspiration risk are key interventions for all hospitalized patients to prevent non-ventilator-associated hospital-acquired pneumonia.Consistent oral care, early and frequent physical activity, and measures aimed to reduce aspiration risk are key interventions for all hospitalized patients to prevent non-ventilator-associated hospital-acquired pneumonia.

Read More

Blood Transcriptomic Analyses Reveal Persistent SARS-CoV-2 RNA and Candidate Biomarkers In Post-COVID-19 Condition

The Lancet
May 06, 2024

The associations among persistent viral RNA, immunometabolism, and patient-reported outcomes provide mechanistic insights for addressing the challenges posed by long COVID.

Read More

Neonatal Diet Type and Associations With Adverse Feeding Outcomes in Neonates With Critical Congenital Heart Defects

JPNN
Apr 09, 2024

Human milk and direct chest/breastfeeding may be protective against some adverse feeding outcomes for CCHD neonates. Larger, multicenter cohort studies are needed to continue investigating the effects of neonatal diet type and feeding modality on the development of adverse feeding outcomes in this unique population.

Read More

Oral Linezolid Compared With Benzathine Penicillin G for Treatment of Early Syphilis in Adults (Trep-AB Study) in Spain

The Lancet
Apr 08, 2024

The efficacy of linezolid at a daily dose of 600 mg for 5 days did not meet the non-inferiority criteria compared with BPG and, as a result, this treatment regimen should not be used to treat patients with early syphilis.

Read More

GPi-DBS-Induced Brain Metabolic Activation in Cervical Dystonia

J Neurol Neurosurg Psychiatry
Apr 01, 2024

GPi-DBS increases metabolic activity at the stimulation site and sensorimotor network. The clinical benefit and adverse effects are mediated by modulation of specific networks.

Read More

Ectopic HCN4 Provides a Target Biomarker for the Genetic Spectrum of mTORopathies

Neuro Genetics
Mar 26, 2024

HCN4 provides a biomarker for the genetic spectrum of mTORopathies and may present a potential therapeutic target for seizure control in mTOR-related epilepsy.

Read More